TBC1D5 and early-onset autosomal dominant Alzheimer disease: Although somewhat speculative, it is tempting to suggest that the interaction between the retromer CSC and TBC1D5 could therefore be an attractive target for therapeutic intervention in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.